Page last updated: 2024-08-26

bosentan anhydrous and E coli Infections

bosentan anhydrous has been researched along with E coli Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hemsén, A; Lundberg, JM; Rudehill, A; Wanecek, M; Weitzberg, E	1

Other Studies

1 other study(ies) available for bosentan anhydrous and E coli Infections

Article	Year
The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Critical care medicine, 1997, Volume: 25, Issue:5 Topics: Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Endothelin Receptor Antagonists; Escherichia coli Infections; Hemodynamics; Hypertension, Pulmonary; Renal Circulation; Shock, Septic; Sulfonamides; Swine	1997

Article

Year

The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.

Critical care medicine, 1997, Volume: 25, Issue:5

Topics: Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Endothelin Receptor Antagonists; Escherichia coli Infections; Hemodynamics; Hypertension, Pulmonary; Renal Circulation; Shock, Septic; Sulfonamides; Swine

1997